Transient elastography improves detection of liver cirrhosis compared to routine screening tests

Table 1 Baseline clinical and biochemical characteristics of all patients

	All	HCV	ASH/NASH	HBV	Cryptogenic	HDV	Other causes
	(n = 291)	(n = 92)	(n = 109)	(n = 35)	(n = 13)	(n = 10)	(n = 32)
Age, yr	54 ± 15	59 ± 13b	53 ± 15	51 ± 13b	59 ± 15	43 ± 9a	50 ± 17a
Gender,%
Female	39.9	41.3	36.7	28.6	38.5	30	59.4a
Male	60.1	58.7	63.3	71.4	61.5	70	40.6
Cirrhosis, %	62.5	76.1	56	68.6	100b	70	25.0d
BMI, kg/m²	25.5 ± 4.2	24.6 ± 3.9a	25.8 ± 4.8	27.2 ± 3.3	25.3 ± 3.0	23.2 ± 4.9	25.2 ± 3.6
Bilirubin, mg/dL	2.7± 4.8	1.5 ± 2.5b	4.3 ± 7.0	1.5 ± 1.5b	1.8 ± 1.3	2.0 ± 1.6	4.1 ± 5.8
Albumin, g/dL	3.6 ± 0.7	3.8 ± 0.6b	3.4 ± 0.7a	3.8 ± 0.7	3.4 ± 0.7	3.4 ± 0.6	3.7 ± 0.4
Immunoglobulins, g/dL	1.7 ± 0.7	1.8 ± 0.7	1.5 ± 0.7	1.7 ± 0.8	1.5 ± 0.4	2.6 ± 0.7b	1.7 ± 0.5
AST, U/L	116 ± 175	100 ± 54	113 ± 187	76 ± 51	70 ± 55	155 ± 94	243 ± 400
ALT, U/L	106 ± 176	102 ± 71	73 ± 100b	72 ± 52	43 ± 20	131 ± 62	300 ± 462a
AFP, μg/L¹	6.2	9.7	5.8	3.4	5.9	7.2	2.9
Platelets, a1000/μL	170 ± 83	152 ± 82	181 ± 79	165 ± 78	168 ± 77	127 ± 74	208 ± 96
Prothrombin time, %	83 ± 18	88 ± 16b	78 ± 21b	85 ± 13	81 ± 23	73 ± 14	86 ± 15

¹Median value.

^aP≤ 0.05;

^bP≤ 0.01 vs all other patients. HCV: Hepatitis C virus; HBV: Hepatitis B virus; HDV: Hepatitis D virus; ASH: Alcoholic steatohepatitis; NASH: Non-alcoholic steatohepatitis.